SCHEMBL6539014

SCHEMBL6539014

Cc1c(C#N)c(C(=O)O)nc(-c2ccccc2)c1-c1ccc(=O)n(C(C)C)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP2C9 P11712 3/20 0.39
ALDH1A1 P00352 3/20 0.39
ADORA2A P29274 3/20 0.39
ADORA1 P30542 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
ACMSD Q8TDX5 1/20 0.37
MEN1 O00255 1/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 2/20 0.36
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 1/20 0.35
GRM5 P41594 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538844 0.79 TP53 (0.37) ALDH1A1ADORA2AADORA1ACMSDTP53
SCHEMBL6539041 0.76 LDHA (0.40) KDM4EHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL5149107 0.75 TP53 (0.37) KDM4EADORA2AADORA1ACMSDTP53
SCHEMBL5147991 0.75 TP53 (0.37) KDM4EADORA2AADORA1ACMSDTP53
SCHEMBL5152639 0.75 PLAU (0.40) KDM4EADORA2ATP53POLB
SCHEMBL6134022 0.74 ADORA2A (0.45) ADORA2AADORA1TP53POLB
SCHEMBL5152899 0.74 USP8 (0.40) KDM4ECYP2C9ALDH1A1ADORA2AADORA1
SCHEMBL6539002 0.73 RET (0.37) KDM4EHSD17B10CYP2C9ALDH1A1ADORA2A
SCHEMBL6539015 0.72 KDM5A (0.42) KDM4ECYP2C9ALDH1A1ADORA2AADORA1
SCHEMBL6134544 0.71 ADORA2A (0.46) ADORA2AADORA1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040067955-A1 Pyridazinone compound and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067955-A1 Pyridazinone compound and pharmaceutical use thereof ADORA1, ADORA2A, P2RX5 KDM4E 3052/4885ALOX15 1415/4885HSD17B10 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.